StockData
Traws Pharma, Inc. logo

Traws Pharma, Inc. (TRAW) stock

TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.24+0.01 (+3.94%)

Close on Nov 18, 2026Market cap $3.73MP/E –Yield –

Traws Pharma revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Traws Pharma's revenue for the twelve months ending Dec 31, 2025 was $2.79M, up 1134.5% year over year. For fiscal 2025 it was $2.79M, up 1134.5% from the year before. Over ten years it grew -13.2% a year on average. The highest annual figure on record is $46.19M in fiscal 2012.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.79M+1134.5%
FY2024Dec 31, 2024$226.00K0.0%
FY2023Dec 31, 2023$226.00K0.0%
FY2022Dec 31, 2022$226.00K0.0%
FY2021Dec 31, 2021$226.00K-2.2%
FY2020Dec 31, 2020$231.00K-89.4%
FY2019Dec 31, 2019$2.18M+77.8%
FY2018Dec 31, 2018$1.23M+56.0%
FY2017Dec 31, 2017$787.00K-85.8%
FY2016Dec 31, 2016$5.55M-51.6%
FY2015Dec 31, 2015$11.46M+1332.0%
FY2014Dec 31, 2014$800.00K-83.2%
FY2013Dec 31, 2013$4.75M-89.7%
FY2012Dec 31, 2012$46.19M+3006.3%
FY2011Dec 31, 2011$1.49M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025$0-100.0%
Q3 FY2025Sep 30, 2025$0-100.0%
Q2 FY2025Jun 30, 2025$2.73M+4694.7%
Q1 FY2025Mar 31, 2025$57.00K+1.8%
Q4 FY2024Dec 31, 2024$56.00K0.0%
Q3 FY2024Sep 30, 2024$57.00K0.0%
Q2 FY2024Jun 30, 2024$57.00K0.0%
Q1 FY2024Mar 31, 2024$56.00K0.0%
Q4 FY2023Dec 31, 2023$56.00K0.0%
Q3 FY2023Sep 30, 2023$57.00K0.0%
Q2 FY2023Jun 30, 2023$57.00K0.0%
Q1 FY2023Mar 31, 2023$56.00K0.0%
Q4 FY2022Dec 31, 2022$56.00K0.0%
Q3 FY2022Sep 30, 2022$57.00K0.0%
Q2 FY2022Jun 30, 2022$57.00K0.0%
Q1 FY2022Mar 31, 2022$56.00K0.0%
Q4 FY2021Dec 31, 2021$56.00K-1.8%
Q3 FY2021Sep 30, 2021$57.00K-13.6%
Q2 FY2021Jun 30, 2021$57.00K+1.8%
Q1 FY2021Mar 31, 2021$56.00K+7.7%
Q4 FY2020Dec 31, 2020$57.00K+90.0%
Q3 FY2020Sep 30, 2020$66.00K+4.8%
Q2 FY2020Jun 30, 2020$56.00K-97.2%
Q1 FY2020Mar 31, 2020$52.00K-23.5%
Q4 FY2019Dec 31, 2019$30.00K-49.2%
Q3 FY2019Sep 30, 2019$63.00K-47.5%
Q2 FY2019Jun 30, 2019$2.02M+316.9%
Q1 FY2019Mar 31, 2019$68.00K-87.9%
Q4 FY2018Dec 31, 2018$59.00K-58.7%
Q3 FY2018Sep 30, 2018$120.00K+9.1%
Q2 FY2018Jun 30, 2018$485.00K+49.7%
Q1 FY2018Mar 31, 2018$564.00K+168.6%
Q4 FY2017Dec 31, 2017$143.00K-17.3%
Q3 FY2017Sep 30, 2017$110.00K-93.3%
Q2 FY2017Jun 30, 2017$324.00K–
Q1 FY2017Mar 31, 2017$210.00K–
Q4 FY2016Dec 31, 2016$173.00K–
Q3 FY2016Sep 30, 2016$1.65M–

More Traws Pharma figures

See a number that looks wrong?